EVENTS:   The Roaring 2020s or a Rerun of the 1970s? - Edward Yardeni/Yardeni Research - 24 Mar 26   Best Equity Short Ideas Conference Call 13 - Thomas Chanos/Badger Consultants & Dr. Aaron Fletcher/Bios Research & Jonathan Telgener/Channel Dynamics & Ed Steele/Iron Blue Financials & John Zolidis/Quo Vadis Capital & Mark Hiley/The Analyst - 26 Mar 26     ROADSHOWS: Chinese Equity Ideas & Channel Checks Across 50 sub-sectors - Don Ma /Horizon Insights   •   London   23 - 27 Mar 26       Long Short European Equity Research - Harry Grist /The Analyst   •   New York   26 Mar 26       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   27 - 27 Mar 26      
Filters

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Entegris (ENTG)

Technology

Abacus Research

A high-quality, defensive, EPS compounder that will out-grow semiconductor volume growth due to trends of increasing purity and material intensity in semis. Furthermore, the benefits from the CMC acquisition could surprise on the upside and are not fully appreciated by the market (the deal represents a step change in establishing a scale advantage over ENTG's competitors). EPS growth will accelerate meaningfully in late 2023 (can compound at ~15% CAGR for the next three years), driven by revenue growth, high incremental margins and cost savings. $5.68 EPS (FY25E) x 20 PE = $114 share price.

Edition: 154

- 17 February, 2023